Medicare Enrolled
Dr. Robert Lemon, MD
Hematology & Oncology · Sequim, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lemon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lemon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lemon
Dr. Robert Lemon is a hematology & oncology specialist in Sequim, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lemon performed 1,343 Medicare services across 837 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lemon received a total of $7,480 from 59 pharmaceutical and/or device companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lemon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in WA
$7,480 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,343
Medicare services
Top 24% in WA for hematology & oncology
837
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
548 | $74 | $197 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
306 | $49 | $135 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
92 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
72 | $10 | $27 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $98 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $114 | $288 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
34 | $13 | $35 |
| Iron level test | 32 | $6 | $17 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
32 | $63 | $142 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
31 | $9 | $22 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $95 | $214 |
| New patient office visit, complex (60-74 min) | 19 | $144 | $400 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
16 | $6 | $16 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
15 | $15 | $38 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
15 | $9 | $24 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
13 | $16 | $42 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
11 | $14 | $37 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,480
Total received (2018-2024)
Avg $1,069/year across 7 years
Top 24% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
366
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,360 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$120 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$181
2023
$389
2022
$1,631
2021
$1,202
2020
$2,222
2019
$1,554
2018
$302
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$66
E.R. Squibb & Sons, L.L.C.
$59
Novartis Pharmaceuticals Corporation
$42
Celgene Corporation
$14
Top 3 companies account for 92.3% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$1,522
E.R. Squibb & Sons, L.L.C.
$1,129
Celgene Corporation
$375
Novartis Pharmaceuticals Corporation
$374
AstraZeneca Pharmaceuticals LP
$323
Shire North American Group Inc
$286
Exelixis Inc.
$269
GlaxoSmithKline, LLC.
$245
Amgen Inc.
$209
Octapharma USA, Inc.
$187
Takeda Pharmaceuticals U.S.A., Inc.
$164
Pharmacyclics LLC, An AbbVie Company
$144
Daiichi Sankyo Inc.
$141
Janssen Biotech, Inc.
$133
Genentech USA, Inc.
$132
Foundation Medicine, Inc.
$115
Gilead Sciences, Inc.
$96
Seagen Inc.
$95
Spectrum Pharmaceuticals Inc.
$95
Regeneron Healthcare Solutions, Inc.
$90
Taiho Oncology, Inc.
$87
Alexion Pharmaceuticals, Inc.
$83
GENZYME CORPORATION
$78
Pharmacyclics LLC, an AbbVie Company
$70
Rigel Pharmaceuticals, Inc.
$68
ABBVIE INC.
$66
Kite Pharma, Inc.
$64
Eisai Inc.
$62
Dova Pharmaceuticals
$49
Seattle Genetics, Inc.
$48
BeiGene USA, Inc.
$46
TerSera Therapeutics LLC
$42
EMD Serono, Inc.
$38
Myovant Sciences Inc.
$37
Sobi, Inc
$36
Karyopharm Therapeutics Inc.
$33
Lilly USA, LLC
$33
Bayer HealthCare Pharmaceuticals Inc.
$30
EISAI INC.
$29
AbbVie Inc.
$28
Advanced Accelerator Applications
$27
Coherus Biosciences Inc.
$25
Heron Therapeutics, Inc.
$25
MorphoSys, US Inc.
$20
G1 Therapeutics, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Ipsen Biopharmaceuticals, Inc
$18
Epizyme, Inc.,
$18
Jazz Pharmaceuticals Inc.
$16
Merck Sharp & Dohme LLC
$16
Incyte Corporation
$16
Astellas Pharma US Inc
$16
Acrotech Biopharma LLC
$16
Deciphera Pharmaceuticals Inc.
$14
Kyowa Kirin, Inc.
$14
Agios Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$12
TESARO, Inc.
$12
PFIZER INC.
$12
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · ALIMTA · Aranesp · BELEODAQ · BLENREP · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · FIBRYGA · Herceptin · ICLUSIG · IMBRUVICA · INJECTAFER · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · NUWIQ · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · Perjeta · Pomalyst · QINLOCK · REBLOZYL · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VONVENDI · VOTRIENT · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XOSPATA · XPOVIO · XTANDI · YERVOY · ZEJULA · ZEPZELCA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
3
Per 100K population
3.9
County median income
$67,999
Nearest hospital
OLYMPIC MEDICAL CENTER
10.3 mi
10.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lemon is a clinical cardiology specialist, with above-average Medicare volume (top 24% in WA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lemon experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lemon performed 548 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lemon receive payments from pharmaceutical companies?
Yes. Dr. Lemon received a total of $7,480 from 59 companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lemon's costs compare to other hematology & oncology specialists in Sequim?
Dr. Lemon's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lemon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sequim
Browse hematology & oncology specialists in Sequim ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology